Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023;23(10):764-777.
doi: 10.2174/1568009623666230413081513.

Probiotics as a Therapeutic Approach in Colorectal Cancer

Affiliations
Review

Probiotics as a Therapeutic Approach in Colorectal Cancer

Nafiseh Rahmani et al. Curr Cancer Drug Targets. 2023.

Abstract

Colorectal cancer (CRC) is a growing concern worldwide. In recent decades, the incidence of CRC has increased, and this has been attributed to changes in lifestyle. The lack of physical activity, smoking habits, and a diet high in red meat and fat and low in fiber are important aspects of these deleterious changes in lifestyle. The increase in the incidence of CRC has impelled researchers to investigate methods for preventing and treating CRC with greater efficacy and fewer complications. Probiotics are an attractive and potentially promising therapeutic approach. They have been evaluated by a large number of preclinical and clinical studies in recent years, and it has been found that they can play a role in the prevention, treatment, and management of complications of CRC. This review provides a concise summary of the mechanisms of action of probiotics. Furthermore, it focuses on the results of clinical and preclinical studies that evaluated probiotics' effects on CRC management. It also discusses the effects of different strains of probiotics and their combination in CRC treatment.

Keywords: CRC management; Colorectal cancer; complications; prevention; probiotics; treatment.

PubMed Disclaimer

Similar articles

Cited by

  • Microbiome and pancreatic cancer: time to think about chemotherapy.
    de Castilhos J, Tillmanns K, Blessing J, Laraño A, Borisov V, Stein-Thoeringer CK. de Castilhos J, et al. Gut Microbes. 2024 Jan-Dec;16(1):2374596. doi: 10.1080/19490976.2024.2374596. Epub 2024 Jul 18. Gut Microbes. 2024. PMID: 39024520 Free PMC article. Review.
  • Microbiome as a biomarker and therapeutic target in pancreatic cancer.
    Pourali G, Kazemi D, Chadeganipour AS, Arastonejad M, Kashani SN, Pourali R, Maftooh M, Akbarzade H, Fiuji H, Hassanian SM, Ghayour-Mobarhan M, Ferns GA, Khazaei M, Avan A. Pourali G, et al. BMC Microbiol. 2024 Jan 5;24(1):16. doi: 10.1186/s12866-023-03166-4. BMC Microbiol. 2024. PMID: 38183010 Free PMC article. Review.

Publication types